Rotigotine Transdermal PatchA Review of its Use in the Treatment of Parkinson’s Disease

被引：0
|
作者：
Mark Sanford
Lesley J. Scott
机构：
[1] Adis,
[2] a Wolters Kluwer Business,undefined
来源：
CNS Drugs | 2011年 / 25卷
关键词：
Levodopa; Pramipexole; Ropinirole; Rotigotine; Morning Motor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
A transdermal patch formulation of the non-ergolinic dopamine agonist rotigotine (Neupro®) is indicated as monotherapy for the treatment of early Parkinson’s disease and as combination therapy with levodopa throughout the course of the disease.
引用
收藏
页码：699 / 719
页数：20
相关论文
共 50 条
  • [31] Rotigotine transdermal system in treatment of patients with advanced-stage Parkinson's disease
    LeWitt, P. A.
    Chang, F-L.
    Fazzini, E.
    Nausieda, P. A.
    Daniel, T.
    Boroojerdi, B.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 : 15 - 16
  • [32] Rotigotine for the treatment of Parkinson's disease
    Morgan, John C.
    Sethi, Kapil D.
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2006, 6 (09) : 1275 - 1282
  • [33] Rotigotine transdermal patch as a treatment of nocturnal symptoms in patients with idiopathic Parkinson's disease
    Chaudhuri, K. R.
    Jankovic, J.
    Trenkwalder, C.
    Boroojerdi, B.
    [J]. MOVEMENT DISORDERS, 2007, 22 : S197 - S197
  • [34] Evaluation of rotigotine transdermal patch for the treatment of apathy and motor symptoms in Parkinson’s disease
    Robert A Hauser
    Jaroslaw Slawek
    Paolo Barone
    Elisabeth Dohin
    Erwin Surmann
    Mahnaz Asgharnejad
    Lars Bauer
    [J]. BMC Neurology, 16
  • [35] Evaluation of rotigotine transdermal patch for the treatment of apathy and motor symptoms in Parkinson's disease
    Hauser, Robert A.
    Slawek, Jaroslaw
    Barone, Paolo
    Dohin, Elisabeth
    Surmann, Erwin
    Asgharnejad, Mahnaz
    Bauer, Lars
    [J]. BMC NEUROLOGY, 2016, 16
  • [36] Evaluation of rotigotine transdermal patch for the treatment of depressive symptoms in patients with Parkinson's disease
    Chung, Sun Ju
    Asgharnejad, Mahnaz
    Bauer, Lars
    Ramirez, Francisco
    Jeon, Beomseok
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (11) : 1453 - 1461
  • [37] Safety and tolerability of transdermal rotigotine in early stage Parkinson's disease
    Watts, Ray L.
    Patton, James M.
    Poewe, Werner
    Boroojerdi, Babak
    [J]. ANNALS OF NEUROLOGY, 2006, 60 : S82 - S82
  • [38] Transdermal rotigotine: a new non-ergot dopamine agonist for the treatment of Parkinson's disease
    Naidu, Y.
    Chaudhuri, K. Ray
    [J]. EXPERT OPINION ON DRUG DELIVERY, 2007, 4 (02) : 111 - 118
  • [39] CabergolineA Review of its Use in the Treatment of Parkinson’s Disease
    Monique P. Curran
    Caroline M. Perry
    [J]. Drugs, 2004, 64 : 2125 - 2141
  • [40] Cabergoline - A review of its use in the treatment of Parkinson's disease
    Curran, MP
    Perry, CM
    [J]. DRUGS, 2004, 64 (18) : 2125 - 2141
12345